Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status (Q34581334)

3 August 2017

title

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Robert N Hoover

1 reference

3 August 2017

Andrew G Glass

1 reference

3 August 2017

James V Lacey

series ordinal

1 reference

3 August 2017

J Daniel Carreon

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 July 2007

1 reference

Journal of the National Cancer Institute

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

1152-1161

1 reference

Rising incidence of breast cancer: relationship to stage and receptor status

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Reported drop in mammography : is this cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Building a research consortium of large health systems: the Cancer Research Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Graphical presentation of trends in rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM059

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM059

1 reference

3 August 2017

1 reference